352

ASOPRS 2024 Fall Scientific Symposium
55th Annual Fall Scientific Symposium of the American Society of Ophthalmic Plastic and Reconstructive Surgery

ASOPRS 2024 Fall Scientific Symposium
55th Annual Fall Scientific Symposium of the American Society of Ophthalmic Plastic and Reconstructive Surgery

Datum
17.10.2024 - 18.10.2024
Symposium
Chicago
Sprache
Englisch
Veranstalter
American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS)
Executive Office
Organisator

American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS)
Executive Office
5841 Cedar Lake Road, Suite 204
US - MN 55416 Minneapolis
Tel.: +1 952 646 2038
Fax: +1 952 545 6073

The ASOPRS as an ICO Member society sponsors several scientific meetings every year to promote education, research and quality of clinical practice in the fields of aesthetic, plastic and reconstructive surgery specializing in the face, orbits, eyelids and lacrimal system. The 55th ASOPRS Fall Symposium will be divided into two major topic days. Exhibitions, posters and awards round off the scientific program.
  • Basisinformation
    Datum
    17.10.2024 - 18.10.2024
    Symposium
    Chicago
    Sprache
    Englisch
    Veranstalter
    American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS)
    Executive Office
    Organisator

    American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS)
    Executive Office
    5841 Cedar Lake Road, Suite 204
    US - MN 55416 Minneapolis
    Tel.: +1 952 646 2038
    Fax: +1 952 545 6073

  • VERANSTALTUNGSORT
    Hilton Palmer House
    17 E Monroe St
    IL 60603 Chicago, US
  • Programm

    Thursday, October 17, 2024
    YASOPRS Eye Openers

    7:01 Rapidly progressive orbital compartment syndrome from ischemic reperfusion injury and rhabdomyolysis.
    7:05 Clinical characteristics, evaluation, management, and prognosis of primary eyelid Merkel cell carcinoma: A systematic review
    7:09 Diagnostic value of Platelet-to-Lymphocyte and Monocyte-to-Lymphocyte Ratios in Differentiating Idiopathic Orbital Inflammation From Orbital Infectious Disease
    7:13 Intraoperative Titration of Eyelid Height and/or Contour during Sutureless Conjunctiva-Sparing Mullerectomy
    7:17 Triangular Anterior Lamellar Optimization Flap for Wedge Resection Repairs of Eyelid Colobomas
    7:21  Q and A
    7:30 Orbital Arteriovenous Fistula Treated with “Altitude Therapy”
    7:34 A large-language-model trained using the ASOPRS Oculofacial Plastic Surgery Education Center web textbook
    7:38 Pickleball-Related Eye Injuries Presenting to United States Emergency Departments, 2010-2023
    7:42 An Analysis of 333 Space-Occupying Lesions of the Orbit at a Comprehensive Pediatric Cancer Center
    7:46 Insurance Status Impacts the Rate of Orbital Fracture and Eyelid Laceration Repair
    7:50 Q and A

     

    Oncology Session

    8:03 Gamma knife radiosurgery versus radiotherapy for primary optic nerve sheath meningioma: outcomes, complications and prognostic factors.
    8:08 Atypical imaging characteristics in patients with epithelial tumors of lacrimal gland
    8:13 Immune Checkpoint Inhibitors for Periocular Squamous Cell Carcinoma with Perineural Spread into Orbit and Skull Base
    8:18 Culprits beside the sun: basal cell carcinoma of the face and eyelid A National Institutes of Health All of Us Research Program Study
    8:23 Mohs Micrographic Surgery with Immunohistochemistry for Periocular Melanoma In-Situ
    8:28 Association between Neighborhood Deprivation and Periocular Skin Cancers Treated with Mohs Micrographic Surgery
    8:33 Comparison of Different Treatment Modalities for Periocular Cutaneous Squamous Cell Carcinoma with Perineural Spread.
    8:38 Q and A


    ASOPRS Foundation Update and Michael J. Hawes Lecture 

    8:55
    John Holds, M.D.
    ASOPRS Foundation Update and Dedication of lecture to Jonathan Dutton, M.D.
    8:59 Eric Steele, M.D. Introduction of Geoffrey Tabin, M.D.
    9:02
    Geoffrey Tabin, M.D.
    “ Impossible dreams - the East face of Mt. Everest and eradicating world blindness”
    9:45  
    Q and A

     

    9:50-10:20 am Break with Exhibitors 

    Orbit Session 

    10:21 A paradigm shift in Congenital Orbital Teratoma: Globe Preserving surgery vs. Exenteration
    10:27 Ophthalmic Outcomes of Transorbital Skull Base Surgery
    10:33 Necrobitic Xanthogranuloma : Clinical Presentation and Management in a Single Center
    10:39 Factors Predicting Mortality and Skull Base Involvement in Patients with Invasive Fungal Sino-Orbital Disease
    10:45 Corneal Neurotization for Neurotrophic Keratitis in Congenital Trigeminal Aplasia: A Case Series
    10:51 The Use of Dilute Hypochlorous Acid in the Treatment of Periorbital Necrotizing Fasciitis
    10:57 Q and A

     

    Eyelid Session 

    11:11 Laudable Pus, Cocaine, and the Evolution of Wound Closure
    11:17 Xanthelasma Palpebrarum is Not Associated with Dyslipidemia or Cardiovascular Disease in a Large Cohort: A Case Control Study
    11:23 Single Suture Frontalis Muscle Flap Advancement: A Modified Technique for Congenital Ptosis Repair
    11:29 Periorbital Distance Prediction and Disease Classification of Oculoplastic Images Using Deep Learning
    11:35 Evaluating AI-Generated Educational Videos for Postoperative Care in Oculofacial Surgery
    11:41 Change in Upper Eyelid Contour following Sutureless Conjunctiva-Sparing Mullerectomy
    11:47 Q and A

     

    12-1 pm Lunch, YASOPRS Lunch and Product Theaters

    Featured Talk

    1-1:02 pm Eric Steele, M.D. Introduction of Roger Dailey, M.D.
    1:02-1:27 pm
    Roger Dailey, M.D.
    "Jones Tubes title TBD"
    1:27-1:35 pm   Q and A

     

    Thyroid Session 

    1:36 Teprotumumab Treatment for Thyroid Eye Disease-Associated Compressive Optic Neuropathy
    1:41 Effect of Smoking in Thyroid Eye Disease: Smokey Fat is a Bulky broken Fat- An Electron Microscopic and Histopathological Study
    1:46 Preliminary Safety and Efficacy of Subcutaneous Lonigutamab (Anti–IGF-1R) from a Phase 1/2 Proof of Concept Study in Patients with Thyroid Eye Disease
    1:51 VRDN-003, Next-Generation Full Antagonist Antibody to IGF-1R: Two Proposed Randomized Placebo-Controlled Clinical Studies in Patients With TED (REVEAL-1 and REVEAL-2)
    1:56 Intravenous steroids versus teprotumumab for the management of thyroid eye disease. Is teprotumumab a game-changer?
    2:01 Monocytes express a functional thyrotropin receptor
    2:06 Teprotumumab Associated Menstrual Changes
    2:11 Orbital decompression in the biologic era: is there a role for surgery?
    2:16 Q and A

     

    Featured Speaker: Aaron Lee, MD

    2:30
    Michael Yoon, M.D.
    Introduction of Aaron Lee, M.D.
    2:32 Aaron Lee, M.D. "Applications of Deep Learning in Ophthalmology"
    2:55   Q and A

     

    3-3:30 pm Break with Exhibitors 

    3:30-5 Breakouts in Eyelid, Aesthetics, and Orbit 


    5-6:30 pm Networking Reception 

    Friday, October 18, 2024
    YASOPRS Eye Openers

    7:01 Patterns and Management of Nodal Metastasis in Patients with Eyelid Sebaceous Carcinoma
    7:05 Immune Checkpoint Inhibitor Therapy for Locally Advanced or Metastatic Periocular Merkel Cell Carcinoma
    7:09 Pre-operative Onyx embolization of large facial intraosseous hemangioma
    7:13 Outcome Comparison of Sphenoid Wing Meningioma Resection with and without Lateral Orbital Wall Reconstruction
    7:17 Thyroid stimulating immunoglobulin as a biomarker for thyroid eye disease prognosis following teprotumumab therapy
    7:21  Q and A
    7:30 Penetrating Transorbital Intracranial Injury Due To Ballpoint Pen
    7:34 Secondary Sebaceous Carcinoma in Retinoblastoma Survivors: A Case Series
    7:38 Umbilical Amniotic Membrane (AM-UC) as a Skin Substitute in Periocular Reconstruction: A Case Series
    7:42 Sutureless Conjunctiva-Sparing Mullerectomy: Pearls and pitfalls from our first 500 cases
    7:46 A Case of Orbital Compartment Syndrome without Evidence of Retrobulbar Hemorrhage or Venous Sinus Thrombosis
    7:50 Q and A

     

    Aesthetics Session

    8:04 Finesse in Forehead Lifting – Asymmetric Release for Asymmetric Ptosis
    8:09 Risk of Blindness in Temple Filler Injections: Exploring Vascular Anastomosis from the Deep Temporal Arteries to the Ophthalmic Artery
    8:14 Micropigmentation for facial and periocular surgical scar camouflage
    8:19 Comparison of the longevity of micro-fat graft in conjunction with each of the products of SVF, ADSC and nano-fat in nude mice model
    8:24 Diagnosis and treatment of filler orbital syndrome
    8:29 Customized Endoscopic Male Forehead/Eyebrow Lift
    8:34 Q and A

     

    Lacrimal/M&M Session

    8:47 Long-term Effects of Orbital Lacrimal Gland Resection for Canalicular Obstruction and Functional Epiphora
    8:53 Bilateral Corneal Neurotization using the Greater Auricular and Posterior Auricular Nerves
    8:59 A Novel Technique for Removal of ‘Hard-to-Find’ Metallic Foreign Bodies in the Posterior Orbit
    9:05 Medial Canthal Eccrine Poroma with Invasion of the Nasal Cavity – Excision and Staged Reconstruction
    9:11 Multidisciplinary Management of Silent Sinus Syndrome
    9:17 Q and A

     

    9:30-10 am OMIC Risk Management 

    10-10:30 am Break with Exhibitors 

    Henry Baylis Lecture 

    10:30 Bob Goldberg Introduction of the Henry Baylis Lecturer: Tanuj Nakra
    10:34 Tanuj Nakra
    Henry Baylis’ Timeless Insights for Oculofacial Surgeons
    10:54
    Questions and Discussion
     
    10:59 Bob Goldberg Presentation of the Henry Baylis Cosmetic Surgery Award

     

    11 am - 12 pm ASOPRS Business Meeting

    12-1 pm Lunch, SASOPRS Lunch, YASOPRS Round Tables, and Product Theaters

    Practice Management, Ethics and Diversity Session 

    1:01 Inflation-Adjusted Changes in Medicare Reimbursement for Commonly Performed Oculoplastics Procedures Over the Last Decade
    1:07 Evaluating Oculoplastics Procedure Waste: A Quality Improvement Study
    1:13 The Impacts of Reimbursement Rates on Oculoplastic Procedure Location Choice: A Discrete Choice Analysis
    1:19 Ocular Trauma Predicts Poor Outcomes in Patients with a History of Intimate Partner Violence
    1:25 The Efficacy of a Midfacial Oxygen Scavenger Mask in Reducing Local Oxygen Concentrations and Oculofacial Surgical Field Fire Risk
    1:31 The current landscape of ASOPRS oculofacial surgeons
    1:37 Emotional Intelligence, Burnout, and Professional Fulfillment among ASOPRS Attendings and Fellows
    1:43 Q and A

     

    Pediatrics Session

    1:56 Dacryocystorhinostomy outcomes for congenital nasolacrimal duct obstruction associated with craniofacial abnormalities
    2:02 Frontalis suspension for congenital ptosis: Re-operation rate and timing based on age at time of surgery
    2:08 Can A Crease Lead the Way? A Single Center Review on Simple Congenital Ptosis Intervention and the Role of Lid Crease Evaluation
    2:14 Severe Chalazion Development in Adolescents with Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor
    2:20 Medial rectus pyomyositis as a complication of orbital cellulitis: A case report
    2:26 Q and A

     

    2:40-3:10 pm Break with Exhibitors 

    3:10-4:30 Facelift Panel

    Thesis Session

    4:31 pm Subperiosteal Abscess of the Orbit: Long-term Trends in Bacteriology and Clinical Outcomes and Current Management Recommendations
    4:35 pm Comparison of kinetic, automated, tangent screen and novel disposable perimetry for the evaluation of dermatochalasis and blepharoptosis
    4:39 pm Award Presentation 


    4:40 pm ASOPRS Awards Session 

    5 pm Adjourn 
     

     

  • Gebühren
    Fachärzte/-innen
    Gebühren ab
    unbekannt
    Ärzte/-innen in Weiterbildung
    Gebühren ab
    unbekannt
    Studenten/-innen
    Gebühren ab
    unbekannt
  • Buchung / Anmeldung

    For further Informations contact the organizer directly.

  • Zertifizierung
    Zertifizierung unbekannt

Veranstaltung teilen